Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NGM Biopharmaceuticals (NGM) stocks in Canada
Learn how to easily invest in NGM Biopharmaceuticals stocks.
NGM Biopharmaceuticals is a biotechnology business based in the US. NGM Biopharmaceuticals stocks (NGM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $21.7 – a decrease of 6.06% over the previous week. NGM Biopharmaceuticals employs 210 staff and has a trailing 12-month revenue of around $76.7 million.
How to buy shares in NGM Biopharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NGM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy NGM Biopharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in NGM Biopharmaceuticals?
- Has coronavirus impacted NGM Biopharmaceuticals shares?
- NGM Biopharmaceuticals shares summary
- Compare share dealing platforms
- Is NGM Biopharmaceuticals stock a buy or sell?
- NGM Biopharmaceuticals performance over time
- NGM Biopharmaceuticals's financials
- How volatile are NGM Biopharmaceuticals shares?
- Does NGM Biopharmaceuticals pay a dividend?
- Other common questions
How has Coronavirus impacted NGM Biopharmaceuticals's stock price?
Since the stock market crash in March caused by coronavirus, NGM Biopharmaceuticals's stock price has had significant negative movement.
Its last market close was $15.96, which is 1.42% down on its pre-crash value of $16.19 and 72.63% up on the lowest point reached during the March crash when the stocks fell as low as $9.245.
If you had bought $1,000 worth of NGM Biopharmaceuticals stocks at the start of February 2020, those stocks would have been worth $693.37 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $939.41.
NGM Biopharmaceuticals stock price (NASDAQ:NGM)Use our graph to track the performance of NGM stocks over time.
NGM Biopharmaceuticals shares at a glance
|Latest market close||$15.96|
|52-week range||$14.90 - $32.12|
|50-day moving average||$18.71|
|200-day moving average||$21.56|
|Wall St. target price||$35.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.62|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
NGM Biopharmaceuticals price performance over time
|1 week (2022-01-06)||-5.79%|
|1 month (2021-12-16)||-9.06%|
|3 months (2021-10-15)||-18.90%|
|6 months (2021-07-16)||-23.64%|
|1 year (2021-01-15)||-41.50%|
|2 years (2020-01-16)||-15.96%|
|3 years (2019-01-12)||N/A|
|5 years (2017-01-12)||N/A|
NGM Biopharmaceuticals financials
|Revenue TTM||$76.7 million|
|Gross profit TTM||$-76,604,000|
|Return on assets TTM||-20.41%|
|Return on equity TTM||-38.4%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
NGM Biopharmaceuticals share dividends
We're not expecting NGM Biopharmaceuticals to pay a dividend over the next 12 months.
NGM Biopharmaceuticals share price volatility
Over the last 12 months, NGM Biopharmaceuticals's shares have ranged in value from as little as $14.9 up to $32.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NGM Biopharmaceuticals's is 1.7751. This would suggest that NGM Biopharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
NGM Biopharmaceuticals overview
NGM Biopharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trial for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an inhibitory antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase Ib clinical trials to inhibit growth differentiation factor GDF15 levels on cancer anorexia/cachexia syndrome; NGM621, an antibody in Phase II clinical trials for the treatment of geographic atrophy; and NGM707 and NGM438, which are in preclinical investigational studies for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp. ; and a collaboration agreement with Merck & Co. , Inc.
Stocks similar to NGM Biopharmaceuticals
Frequently asked questions
NGM Biopharmaceuticals in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Hedge Funds Are Crazy About NGM Biopharmaceuticals, Inc. (NGM)
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
Ask an Expert
You must be logged in to post a comment.